SCHEMBL877138

SCHEMBL877138

O=C1NC(=O)C2(N1)c1ccccc1Oc1ccccc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 1/20 0.65
CYP2C9 P11712 2/20 0.53
CACNA1F O60840 1/20 0.53
ALDH1A1 P00352 1/20 0.53
MAPT P10636 1/20 0.53
HTR2A P28223 1/20 0.53
HRH1 P35367 1/20 0.53
SCN1A P35498 1/20 0.53
SCN4A P35499 1/20 0.53
BLM P54132 1/20 0.53
PMP22 Q01453 1/20 0.53
CACNA1D Q01668 1/20 0.53
KCNH2 Q12809 1/20 0.53
CACNA1S Q13698 1/20 0.53
CACNA1C Q13936 1/20 0.53
SCN5A Q14524 1/20 0.53
SCN2A Q99250 1/20 0.53
SCN3A Q9NY46 1/20 0.53
AKR1B1 P15121 11/20 0.50
AKR1A1 P14550 7/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23998300 0.82 AKR1B1 (0.67) ITGA4CYP2C9CACNA1FALDH1A1MAPT
SCHEMBL23178755 0.79 ITGA4 (0.45) ITGA4CYP2C9CACNA1FALDH1A1MAPT
SCHEMBL9810959 0.79 ITGA4 (1.00) ITGA4CYP2C9CACNA1FALDH1A1MAPT
SCHEMBL31195728 0.79 ITGA4 (1.00) ITGA4CYP2C9CACNA1FALDH1A1MAPT
SCHEMBL874458 0.76 ITGA4 (0.42) ITGA4CYP2C9CACNA1FALDH1A1MAPT
SCHEMBL9810971 0.76 AKR1B1 (0.69) MAPTAKR1B1AKR1A1
SCHEMBL11100706 0.76 ITGA4 (0.67) ITGA4CYP2C9CACNA1FALDH1A1MAPT
SCHEMBL23178807 0.74 ITGA4 (0.40) ITGA4CYP2C9CACNA1FALDH1A1MAPT
SCHEMBL3035791 0.73 ITGA4 (0.63) ITGA4CYP2C9CACNA1FALDH1A1MAPT
SCHEMBL11018163 0.73 ITGA4 (0.44) ITGA4ALDH1A1MAPTBLMAKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021061763-A1 ALDOKETO REDUCTASE INHIBITORS AND USES THEREOF CASE WESTERN RESERVE UNIVERSITY (US) 2021-04-01 WO disclosed
WO-2012040641-A2 COMPOUNDS FOR TREATING NEURODEGENERATIVE DISEASES ARRAY BIOPHARMA INC. (US) 2012-03-29 WO disclosed
EP-0092385-B1 HYDANTOIN DERIVATIVES FOR USE IN INHIBITING ALDOSE REDUCTASE ACTIVITY, COMPOSITIONS THEREFOR AND PROCESS FOR PREPARING SPIRO-FLUOREN COMPOUNDS ALCON LABORATORIES, INC. (US) 1991-06-12 EP disclosed
US-4540700-A Treatment of diabetic complications with certain spiro-imidazolidine-diones ALCON LABORATORIES, INC. (US) 1985-09-10 US disclosed
US-4436745-A TETRACYCLIC SPIROHYDANTOINS ALCON LABORATORIES, INC. (US) 1984-03-13 US disclosed
WO-1983003543-A1 METHOD OF INHIBITING ALDOSE REDUCTASE ACTIVITY, COMPOSITIONS THEREFOR AND PROCESS FOR PREPARING SPIRO-FLUOROFLUOREN AND SPIRO-DIFLUOROFLUOREN COMPOUNDS ALCON LAB INC (US) 1983-10-27 WO disclosed
EP-0092385-A2 Hydantoin derivatives for use in inhibiting aldose reductase activity, compositions therefor and process for preparing spiro-fluoren compounds ALCON LABORATORIES, INC. (US) 1983-10-26 EP disclosed